ãã¨ã¯ã¹ã¿ã·ã¼ã®ã´ãããã¡ã¼ã¶ã¼ãã¨å¼ã°ãã¦ããã¢ã¬ã¯ãµã³ãã¼ã»ã·ã¥ã«ã®ã³å士ãä»æ2æ¥ã88æ³ã§äº¡ããªã£ãã¨ã®ãã¨ãæ»å ã¯èºçï¼International Business TimesãSlashdotï¼ã æ°ã¯ä½ç¾ã¨ããåç²¾ç¥è¬ã®åæããã³çºè¦ããã¦ãããã¾ãèªèº«ã妻ã¨ä¸ç·ã«ãã®å¹æã試ãã¦ã¯çµæãè¨é²ãããã®å 容ã2åã®æ¬ã«ã¾ã¨ãã¦ãããéå»ã®ã¤ã³ã¿ãã¥ã¼ã§ã¯ã人çã®ãã¡ã§4ååã¯åç²¾ç¥è¬ã§ããã¤ã«ãªã£ããã¨çãã¦ããããã£ã¨è¨ç®ããã°ã1é±éã«1åã®ãã¼ã¹ã50å¹´éç¶ãã¦ããã¨ãããã¨ã«ãªãã ã·ã¥ã«ã®ã³æ°ã¯ãåæ麻è¬ã®ä¸ç¨®ã§ããMDMAã«é¢ãããå績ãã§ãç¥ããã¦ãããMDMAã¯ã¯1912å¹´ã«Anton Kollischæ°ã«ãã£ã¦åæããããã®ã ãããã®å¾ãã°ããã¯ãã®åå¨ã¯å¿ãããã¦ãããããã1976å¹´ã«ã·ã¥ã«ã®ã³æ°ããã®å¹æã試ãã1978å¹´ã«MDMAã人éã«ä¸ãããã©ã¹ã®
ââ社åã«ããªã£ã¦ãããã°ãªã³ãã¯ããã°ãªã³ã¼ã²ã³ãããã¨ã£ãã¨èãã¾ããããããããªãã§ããã©ãã°ãªã³ã¼ã²ã³ã£ã¦ä½ãªã®ã§ããããï¼ æ æ¨ï¼ãããã°ãªãã«ãã®ãå¸ãç©ã£ã¦ãããããªä¹³ç½è²ã«æ¿ã£ã¦ãã¾ããããããã¯ã°ãªã³ã¼ã²ã³ã溶ãã¦ããè²ãªãã§ãããèåã®ã°ãªã³ã®ä¸ã«ã¯ãã«ãããæ½åºããã°ãªã³ã¼ã²ã³ãå ¥ã£ã¦ãã¾ãã ââã«ãâ¦â¦ããããã°ãã°ãªã³ã®åµæ¥ã¨ãã½ã¼ããã«ãã®è©±ã§ããããåµæ¥è ã®æ±å´å©ä¸ããããæ¼å¸«ãæ¨ã¦ã¦ããã«ãã®ãã身ã®ç ®æ±ããç æ°ï¼ããã¹ï¼ã®æ¯åã«é£²ã¾ãããå æ°ã«ãªã£ããã«ãã®ç ®æ±ã«ã¯ã°ãªã³ã¼ã²ã³ãããããå«ã¾ãã¦ãããããã§ãã£ã©ã¡ã«ã«ã°ãªã³ã¼ã²ã³ãå ¥ãã¦ãæ é¤èåã°ãªã³ããèªçãããã¨ã大æ£åæã®è©±ã¨èãã¦ãã¾ãããå¹³æã®ä»ã§ãããèåã®ã°ãªã³ã«ã¯ã«ãããåã£ãã°ãªã³ã¼ã²ã³ãå ¥ã£ã¦ãããã§ããï¼ æ æ¨ï¼ããããä»ã®ã°ãªã³ã«ããã«ãããåã£ãã°ãªã³ã¼ã²ã³ãå ¥ã£ã¦ãããã§ã
å¡©ç´ æåã§ã¦ã¤ã«ã¹ãé¤èããã¨ããã£ãæºå¸¯å空éé¤èå¤ãã¦ã¤ã«ã¹ãããã¯ã¿ã¼ãã§ããã©ã®è¢«å®³äºä¾ãç¸æ¬¡ãã§ããã¨ãã¦ãæ¶è²»è åºã¯ï¼ï¼æ¥ãããã®è£½åã®ä½¿ç¨ãç´ã¡ã«ä¸æ¢ãã¦ã»ãããã¨å¼ã³ãããã ãåé¡ã®è£½åã¯ä¸å½ã§è£½é ããããã®ã§ãããã¤ãã¯ã³ã¼ãã¬ã¼ã·ã§ã³ãï¼ç³å·çï¼ãï¼æï¼ï¼æ¥ã«è²©å£²ãæ¼ç½å¤ãªã©ã«å«ã¾ãã次äºå¡©ç´ é ¸ãããªã¦ã ãå«ãé å¤ã®å ¥ã£ãããã¯ãé¦ããããã¦ä½¿ããã¨ã§ãã¦ã¤ã«ã¹ãé¤èã§ããã¨ãã¦ããã ãã¨ããããä»æï¼æ¥ã«åèçã§å¹¼å ãéå·ã®åå¦ããã©ãè² ããã»ãã«ãå°ãªãã¨ãåå°ã§ï¼ä»¶ã軽å·ã®è¢«å®³äºä¾ãå ±åãããã ãæ¶è²»è åºã«ããã¨ãé å¤ã«æ±ãªã©ã®æ°´åãå«ã¾ããã¨å¼·é ¸æ§ã«ãªããæã®ä¸ããã§ãç®èã«å¼·ãåºæ¿ãä¸ããæããããã¨ããããç®èã赤ããªã£ããã¾ãæ´ãæµããæ©ãã«ç®èç§ã«å診ãã¦ã»ãããã¨å¼ã³ããã¦ããã
ä¸è¬çãªè©±é¡ ãéå ±ã2012å¹´ãã¼ãã«åå¦è³çºè¡¨ï¼ï¼ãGã¿ã³ãã¯è³ªå ±å½¹å容ä½ã«é¢ããç 究ã 2012/10/10 ä¸è¬çãªè©±é¡, åå¦è ã®ã¤ã¶ãã æ稿è : cosine ã±ã ã¹ãã§ã大ã çã«Facebooké£åäºæ³ä¼ç»ãè¡ã£ã¦ãã¾ããåå¦è³ãã¾ãããè¦äºã«å¤ãã¾ããã»ã»ã»ãã£ãããæ ãããåè³è ã¯ä¸¡è ã¨ãç±³å½ã®ç 究è ã§ããã¥ã¼ã¯å¤§å¦ã®Robert J. Lefkowitz (ããã¼ãã»ã¬ãã³ããã)ææã¨ã¹ã¿ã³ãã©ã¼ã大å¦ã®Brian K. Kobilka (ãã©ã¤ã¢ã³ã»ã³ãã«ã«)ææã®ï¼äººã§ãã ãã¼ããå½ã¦ãã®ã¯ã»ãã¨ãã«é£ããã§ããã»ã»ã»ç¹ã«çåå¦ç³»ã®ãã®ã¨ãªãã¨ãå°éå¤ã«ãªã£ã¦ãããã¨ããããã©ãã«ãäºæ³ãã«ããã¨ããã ãããä»å¹´ã®åè³å¯¾è±¡ã¨ãªã£ãã®ã¯ããGã¿ã³ãã¯è³ªå ±å½¹å容ä½(G protein-coupled recepter, GPCR)ãã«é¢ããç 究ã«ã¤ãã¦ã çè ã®
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}